Pages that link to "Q74673844"

The following pages link to The biology of ovarian cancer (Q74673844):

Displaying 43 items.

• Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors (Q24791749) (← links)
• Antigen-specific immunotherapy of cervical and ovarian cancer (Q27488697) (← links)
• SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells (Q28345301) (← links)
• The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts (Q30422138) (← links)
• Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas (Q33521701) (← links)
• Mucins in ovarian cancer diagnosis and therapy (Q33583166) (← links)
• The role of dysregulated glucose metabolism in epithelial ovarian cancer (Q33674221) (← links)
• Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells (Q33685268) (← links)
• Ovarian cancer: pathology, biology, and disease models (Q33807748) (← links)
• A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas (Q33816666) (← links)
• Molecular genetics complexity impeding research progress in breast and ovarian cancers (Q33858073) (← links)
• Ovarian cancer development and metastasis (Q34086819) (← links)
• Whole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouse (Q34088165) (← links)
• Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer. (Q34098058) (← links)
• Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas (Q34230001) (← links)
• Conditional knockout ofbrca1/2andp53in mouse ovarian surface epithelium: Do they play a role in ovarian carcinogenesis? (Q34389214) (← links)
• Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial (Q34624404) (← links)
• The dominance of the microenvironment in breast and ovarian cancer (Q34654993) (← links)
• Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model (Q34769954) (← links)
• MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells (Q35035434) (← links)
• Diverse tumorigenic pathways in ovarian serous carcinoma (Q35789009) (← links)
• Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor (Q35855100) (← links)
• Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors (Q35859678) (← links)
• In vivo tumor growth of high-grade serous ovarian cancer cell lines (Q35927115) (← links)
• Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma (Q36065252) (← links)
• Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer. (Q36121695) (← links)
• Mechanisms and Targets Involved in Dissemination of Ovarian Cancer (Q36180735) (← links)
• Germline cells in ovarian surface epithelium of mammalians: a promising notion. (Q36594506) (← links)
• Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells (Q36752057) (← links)
• Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype (Q37033992) (← links)
• Expression and mutational analysis of c-kit in ovarian surface epithelial tumors (Q37323849) (← links)
• Calcium-sensing receptor in cancer: good cop or bad cop? (Q37326557) (← links)
• Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. (Q37326840) (← links)
• Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors (Q38462384) (← links)
• Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression (Q39188061) (← links)
• DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer (Q39711357) (← links)
• Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro (Q40161313) (← links)
• Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens. (Q45259839) (← links)
• Histology of the Ovary of the Laying Hen (Gallus domesticus). (Q47205571) (← links)
• Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes. (Q52725941) (← links)
• Quercetin: a natural compound for ovarian cancer treatment. (Q64929167) (← links)
• Quantification of Berberine in Berberis vulgaris L. Root Extract and Its Curative and Prophylactic Role in Cisplatin-Induced In Vivo Toxicity and In Vitro Cytotoxicity (Q93082101) (← links)
• Stem Cells in Ovarian Cancer and Potential Therapies (Q98293351) (← links)